SMTL ID : 3ztc.3 (3 other biounits)

pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)pyrrolidine-2- carboxamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x TR0: (4R)-N-(BIPHENYL-4-YLMETHYL)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLINAMIDE(Non-covalent)

TR0.1: 12 residues within 4Å: Chain C: N.17, W.38, F.41, Y.48, P.49, L.51, I.59, H.60, S.61, Y.62, H.65, W.67 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:P.49, C:L.51, C:I.59, C:I.59, C:Y.62, C:W.67 Hydrogen bonds: C:W.38, C:H.60, C:H.65 pi-Stacking: C:Y.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Van Molle, I. et al., Dissecting Fragment-Based Lead Discovery at the Von Hippel-Lindau Protein:Hypoxia Inducible Factor 1Alpha Protein-Protein Interface. Chem.Biol. (2012)

Release Date

2012-07-25

Peptides

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2: A
TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1: B
VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

B
H

C
I

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1

VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR

Related Entries With Identical Sequence